A Multifactorial Case of Acquired Hemophilia A

Key Points

• Effective management of bleeding episodes is crucial in acquired hemophilia A cases, which are rare.
• The presence of autoantibodies against coagulation factors complicates treatment strategies and patient outcomes.
• Assessment of management strategies involved close monitoring and tailored interventions to minimize bleeding risks over time.
• Findings may enable better approaches to handle the complexities of acquired hemophilia A in clinical practice.